Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages
about
MicroRNA Dysregulation in Cystic FibrosisTRPC6 channel translocation into phagosomal membrane augments phagosomal functionUnderstanding protein kinase CK2 mis-regulation upon F508del CFTR expressionMicroglia sculpt postnatal neural circuits in an activity and complement-dependent mannerSecond-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-raftsLysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular ToxicityPresynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus2D luminescence imaging of pH in vivo.The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cellsDysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa.Neutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice.Reactive-oxygen-species-mediated P. aeruginosa killing is functional in human cystic fibrosis macrophages.Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis.Pseudomonas aeruginosa-induced bleb-niche formation in epithelial cells is independent of actinomyosin contraction and enhanced by loss of cystic fibrosis transmembrane-conductance regulator osmoregulatory function.Cystic Fibrosis Gene Therapy in the UK and Elsewhere.Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing.Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungsActivation of Hepatic STAT3 Maintains Pulmonary Defense during EndotoxemiaX-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect.Intracellular chloride channel protein CLIC1 regulates macrophage function through modulation of phagosomal acidification.Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate.Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.Low levels of insulin-like growth factor-1 contribute to alveolar macrophage dysfunction in cystic fibrosis.Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator.Simultaneous TCR and CD244 signals induce dynamic downmodulation of CD244 on human antiviral T cells.Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation.Impaired defenses of neonatal mouse alveolar macrophage with cftr deletion are modulated by glutathione and TGFβ1Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation.Immune responses in cystic fibrosis: are they intrinsically defective?A review of reagents for fluorescence microscopy of cellular compartments and structures, part I: BacMam labeling and reagents for vesicular structures.Self-assembled hydrogel fibers for sensing the multi-compartment intracellular milieu.Inflammation and its genesis in cystic fibrosis.NAADP/TPC2/Ca(2+) Signaling Inhibits Autophagy.Chloride flux in phagocytes.Staphylococcus aureus Survives in Cystic Fibrosis Macrophages, Forming a Reservoir for Chronic Pneumonia.Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.Two pore channel 2 (TPC2) inhibits autophagosomal-lysosomal fusion by alkalinizing lysosomal pH.Lysosomal pH and analysis of the counter ion pathways that support acidification.Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
P2860
Q26799762-D1D36214-EECD-4644-9A20-AA0BA10E1D78Q27317729-320E9D10-DB2E-4195-8D2D-B3185D799709Q27694649-BCCF49A7-0F4C-40A3-9BC8-EACA548A799EQ28267444-5E1358AF-A86C-48A1-83A1-A529D66CFA89Q28544815-E1600D35-1BEE-4BBC-87DE-7F02C6D62456Q28555118-3C5263CE-9513-4EAB-AFBE-A94EEFCC94C9Q28568030-DDA50066-10D5-42AE-989D-4995C5D60FF7Q30498170-6CBCE22E-7488-4241-B1C7-D8B503012997Q33742138-18396A78-91DC-4D84-BC59-CE0A12CEEBE4Q33916871-A2508102-DD96-4B66-8307-14CF5CF91BFEQ34128926-A22E7311-5F9E-4C0F-B0D0-55474D9487E2Q34971998-777DFF57-7D9A-49B0-93DD-A2B8DD3923A2Q35034255-D2757CF3-44BA-41A4-B821-F72ACE2632EBQ35172336-15C9D8A0-9463-466F-A674-0F370A2DD938Q35641704-E64D50AE-9ABF-4DB6-AC9F-137F705BA7D9Q35749642-DCA25F7E-AB1B-4C71-A107-D0027D58E756Q35816416-633ADF43-E423-44D5-A762-6A756F80BEB0Q36053579-9421176B-0FF6-4228-874F-072B03DDFE7FQ36516884-F8917F42-C7D2-462C-874D-224F71E450F8Q36547077-DD0A3C91-C568-45FB-850F-D8BF3E5FB2D6Q36580526-B2BC4A33-64D7-48B6-BA74-670C707835C5Q36692593-BA3DAFC1-30C6-48DF-8A6A-7414DDDC1E3AQ36709312-F250DC90-AD9F-472A-BB66-41871E272A2EQ36951634-04F15DEA-6570-4608-8478-76A0469B21D6Q37011814-066049A7-6B08-4950-8004-800FFA2AF7A3Q37184787-54D67A6A-56BB-44EE-9117-18FAAAB04193Q37631563-0BED1925-6B10-4EE1-968F-E4F4A1996052Q37727368-4BD91287-04E7-4B26-A474-0494422DD7B0Q37744944-26805E18-5AED-49AC-A4DD-ACCADE256AA4Q37992061-ADAA7A81-61F1-4922-A410-90F52CAB104EQ38120166-81D6A302-0DB4-4C98-8F38-AE9139EAE9D2Q38516891-8C849182-3B42-485E-8AE2-FE71866A9A79Q38579962-9B49F753-0B9B-431B-876D-812D01ECEE89Q38717578-62665CF5-7648-40CC-A38A-6B4F3AF86C4CQ38936533-3CCB6F73-D6CE-459F-B420-AD8C2BBB9E15Q40295903-2C2D7AA0-F6CD-42EE-AD9E-790B7B5DF7D1Q41440235-0C8053D8-EFA1-4BA0-BFAB-F711DCFAE285Q41820235-EB92AA58-4ACB-4E8C-AB66-5E44743A27DDQ42701126-2A5F7FB4-7836-4FF6-8D26-352D2530F557Q45198935-97C01D16-0258-41C4-897E-08A8FE57C167
P2860
Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disease-causing mutations in t ...... ponses of alveolar macrophages
@en
Disease-causing mutations in t ...... onses of alveolar macrophages.
@nl
type
label
Disease-causing mutations in t ...... ponses of alveolar macrophages
@en
Disease-causing mutations in t ...... onses of alveolar macrophages.
@nl
prefLabel
Disease-causing mutations in t ...... ponses of alveolar macrophages
@en
Disease-causing mutations in t ...... onses of alveolar macrophages.
@nl
P2093
P2860
P921
P356
P1476
Disease-causing mutations in t ...... ponses of alveolar macrophages
@en
P2093
Alexander J Gallan
Daniel W Beacham
Deborah J Nelson
Erwin A Gomez
Guangping Zhang
Jessika A Hopson
Ludmila V Deriy
Pavel D Shevchenko
Vytautas P Bindokas
P2860
P304
35926-35938
P356
10.1074/JBC.M109.057372
P407
P577
2009-12-01T00:00:00Z